In short
- Twenty-four recently detoxified adults with severe alcohol use disorder and depressive symptoms received either 25 mg or 1 mg of psilocybin.
- Three weeks later, the high-dose group was less slowed down by their own point of view when judging what another person could see.
- The authors read this as reduced egocentricity: less interference from the self, rather than greater sensitivity to others.
What the researchers did
This was a secondary analysis of a small double-blind pilot trial. Before and after the psilocybin session, participants did a visual perspective-taking task: they had to judge what an on-screen figure could see, while their own view sometimes pointed to a different answer. The researchers measured how much one’s own perspective got in the way (egocentric bias) and how much the other’s perspective got in the way (altercentric bias).
What they found
In the 25 mg group, the self-perspective slowed people down less after treatment, and this reduction was larger than in the 1 mg group. Accuracy and altercentric bias did not change. People who had a more intense psychedelic experience showed a lower “egocentric superiority” on accuracy, although that link was exploratory.
Why it matters
Many people describe a deep psychedelic experience as stepping outside the narrow room of the self for a while. This study gives a modest, measurable echo of that: for a few weeks afterwards, one’s own point of view seemed to have a little less grip. In our work we see that this loosening can make room for empathy, forgiveness and new ways of relating, but only if it is held and brought into daily life. That is why integration matters as much as the experience itself.
Keep in mind
This is a preprint with 24 participants in two unequal groups (18 and 6). It measured one laboratory task, not drinking, depression or real-life relationships, and the findings need replication.
Making sense of an experience
Our psychologists and psychotherapists offer one-to-one integration sessions, online or in Edinburgh.
Integration therapyThis summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.
You may also like
When the Self Falls Quiet: Ego Dissolution and the Language of the Self
A brain-imaging study found that during strong ego dissolution on psilocybin, people’s language and meaning networks became more alike.
Dr Christoph Zwolan · 12 November 2026
ResearchWhen Nothing Feels Good: Can Psilocybin Help Bring Back Joy?
A small trial tested psilocybin with psychological support for anhedonia, the loss of pleasure, in treatment-resistant depression. The results were mixed but hopeful.
Monika Knitter · 6 November 2026
ResearchKinder to Ourselves: Self-Compassion and Lasting Change After MDMA Therapy
In MDMA-assisted therapy for social anxiety, self-compassion rose during sessions and kept growing, and it was linked with less shame and more belonging.
Danielle Tanner · 3 November 2026
